PAVmed (PAVM) Profit After Tax Growth (1y) (2016 - 2025)
PAVmed (PAVM) Profit After Tax Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.04% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 4.70% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -27.13% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 108.33% |
| 10 | PAVmed | 11.39 Mn | 9.86 Mn | -4,000.00 | 81.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 81.46% |
| Jun 30, 2025 | -13.83% |
| Mar 31, 2025 | 200.60% |
| Dec 31, 2024 | -541.08% |
| Jun 30, 2024 | 39.49% |
| Mar 31, 2024 | -3.24% |
| Dec 31, 2023 | 88.66% |
| Sep 30, 2023 | 16.75% |
| Jun 30, 2023 | 29.90% |
| Mar 31, 2023 | 8.67% |
| Dec 31, 2022 | -3.97% |
| Sep 30, 2022 | -91.15% |
| Jun 30, 2022 | -101.46% |
| Mar 31, 2022 | -106.53% |
| Dec 31, 2021 | -125.16% |
| Sep 30, 2021 | -149.28% |
| Jun 30, 2021 | -127.14% |
| Mar 31, 2021 | 34.33% |
| Dec 31, 2020 | -33.35% |
| Sep 30, 2020 | -77.73% |